Dorman Products, Aegon, Genmab, ScanSource, and Gold Fields Limited have been added to the Zacks Rank #1 (Strong Buy) List today. Their current year earnings estimates have increased 11.5%, 10.1%, 10.1%, 7.9%, and 7% respectively over the last 60 days.
Today, Dorman Products (NASDAQ: DORM), Aegon (NYSE: AEG), Genmab (CSE: GENM), ScanSource (NASDAQ: SC), and Gold Fields Limited (NYSE: GFI) were added to the Zacks Rank #1 (Strong Buy) List. This move is based on significant upward revisions in their current year earnings estimates over the last 60 days. The earnings estimates for these companies have increased by 11.5%, 10.1%, 10.1%, 7.9%, and 7% respectively.
Dorman Products, an auto parts manufacturer, has seen its stock price rise due to positive analyst ratings. Stephens and Roth Capital have both initiated coverage with "overweight" ratings and price targets of $185.00 and $182.00 respectively, indicating a potential upside of 22.09% and 17.25% from their previous close
Dorman Products (NASDAQ:DORM) Earns Overweight Rating from Analysts at Stephens[1].
Aegon, a global life insurance company, was upgraded from a "hold" to a "strong-buy" rating by Zacks Research and Wall Street Zen
Aegon (NYSE:AEG) Upgraded at Zacks Research[2]. This upgrade comes as institutional investors and analysts express confidence in the company's growth prospects.
Genmab, a biotechnology company, has also seen an increase in its earnings estimates, reflecting positive sentiment among analysts. Similarly, ScanSource, a technology solutions provider, and Gold Fields Limited, a mining company, have seen their earnings estimates rise, indicating a potential for increased profitability.
These upgrades highlight the growing optimism among financial professionals and investors about the future prospects of these companies. As always, investors should conduct thorough research and consider their risk tolerance before making any investment decisions.
Comments
No comments yet